GENEVA, Sept. 21 -- WUHAN YZY BIOPHARMA CO., LTD. (Biolake, C2-1, No. 666 Gaoxin Road, Donghu New Technology Development ZoneWuhan, Hubei 430075), 武汉友芝友生物制药股份有限公司 (中国湖北省武汉市东湖技术开发区高新大道666号光谷生物城C2-1) filed a patent application (PCT/CN2025/082309) for "METHOD FOR AMELIORATING OR TREATING MALIGNANT ASCITES USING ANTI-EPCAM x CD3 BISPECIFIC ANTIBODY" on Mar 13, 2025. With publication no. WO/2025/190337, the details related to the patent application was published on Sep 1...